Industry News

Stay up to date with the latest news in the pharmaceutical industry

LATEST NEWS

Novartis Moves for Potent Hepatitis C Treatment

Novartis has moved to seal an exclusive licence agreement with Swiss group Debiopharm for the development, manufacture and commercialisation of Debio 025 (alisporivir), which has shown a potent effect on the hepatitis C virus (HCV).

09 February 2010





Newsletter Sign-Up
For all the latest news in the pharmaceutical industry, sign up here

Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Events & Exhibitions
Newsletter Archive
Newsletter Sign-Up
Advertise With Us
About Us
Client Area


RSS What is RSS
The website for the pharmaceutical industry